化合物简介
Abexinostat (INN, formerly PCI-24781) is an experimental drug candidate for cancer treatment. It is currently under development by Pharmacyclics and is in Phase II clinical trials for B-cell lymphoma. Pre-clinical study suggests the potential for treatment of different types of cancer as well.
基本信息
中文名称
3-[(二甲基氨基)甲基]-n-[2-[4-[(羟基氨基)羰基]苯氧基]乙基]-2-苯并呋喃羧酰胺
英文名称
3-[(dimethylamino)methyl]-N-[2-[4-(hydroxycarbamoyl)phenoxy]ethyl]-1-benzofuran-2-carboxamide
中文别名
英文别名
3-((dimethylamino)methyl)-N-(2-(4-(hydroxycarbamoyl)phenoxy)ethyl)benzofuran-2-carboxamide、3-[(dimethylamino)methyl]-N-{2-[4-(hydroxycarbamoyl)phenoxy]ethyl}-1-benzofuran-2-carboxamide、ABEXINOSTAT
CAS号
783355-60-2
分子式
C21H23N3O5
分子量
397.424
精确质量
397.164
PSA
107.53
LOGP
3.3879
编号系统
MDL号
MFCD10565969
物化性质
储存条件
at -20ºC 2 years
